Biomedical Molecular Engineering Lab

Welcome TO THE BIOMEDICAL MOLECULAR ENGINEERING

& dISEASE CONTROL LAB @ KHU

The Biomedical Molecular Engineering Laboratory designs and constructs biopharmaceutical platforms and applies them to both understand the molecular biological pathogenesis of various diseases such as cancer and inflammatory diseases and develop therapeutic strategies for them.

The lab is currently developing its own therapeutic platforms including CRISPR Self Check-In, mRNA Bridge Mimetics, EpiActivator, and EpiRepressor for curing diseases. We are currently very interested in developing biotherapuetics for treatment of various degenerative diseases.

Laboratory of Biomedical Molecular Engineering's Recent Researches

CRISPR Self Check-In for Cell-Type Specific Genome Editing

Engineered Fusion Protein for Disease Specific Genome Regulation (Shin et al. J. Immunol & Shin et al. NAR 2022)

EpiActivator & EpiRepressor for Cell Fate Control

Epigenome Engineering for Reverse Aging (Tran et al. Molecular Therapy Nucleic Acids 2025)

Engineered Stem Cell Platform

As Interactive Therapeutic Platform

Responsive Drug Treatment for Inflammatory Disease (Kim et al. ACS AMI 2022 & Kim et al. Nano Today 2022)

Prediction Model via Machine Learning

Epigenome Reprograming for Controlling Disease

Prime Editing Technology

Prime Editing for PKU Treatment

Generative AI for Designing

Therapeutic Proteins

AI-guided Design of Therapeutic Platforms Targeting Pathlogical Signaling Pathways

Join our exciting research journey!

Research in the BMME supported by

BMME Lab

Department of Genetics and Biotechnology

Kyung Hee University

1732 Deogyeong-daero, Giheung-gu, Yongin-si, Gyeonggi-do 17104, Republic of Korea

Contact: Professor. Seung Ja Oh, Ph.D at seungja.oh@khu.ac.kr

Page updated

Google Sites

Report abuse